patients, customised precision oncology is not successful in every case. A research group led by Professor Dr. Arndt Vogel, senior consultant at the Department of Gastroenterology, Hepatology and Endocrinology [...] FGFR2 inhibitors, or identify the patients for whom the therapy is a promising option," explains Professor Dr. Vogel. A combination therapy against these gene alterations could make the cancer cells susceptible

knowledge reaches those affected directly," says Professor Brigitte Schlegelberger, head of the FBREK Centre and the Institute of Human Genetics at the MHH. Professor Dr. Peter Hillemanns, Director of the Com

Which factors control the different development was unknown for a long time. A research team led by Professor Dr. Andreas Kispert and Dr. Mark-Oliver Trowe from the Institute of Molecular Biology at the Hannover [...] cochlea in the mouse model and found that Tbx2 is active exclusively in the inner hair cells," says Professor Kispert. If Tbx2 was specifically switched off in the precursor cells, no more inner hair cells

provide a robust and comprehensive data set for counselling and care of families with FA and AT" said Professor Christian Peter Kratz, Director of the Department of Paediatric Haematology and Oncology, Head of [...] Gerdes Foundation and the Schroeder-Kurth Fund. SERVICE: For further information , please contact Professor Dr. Christian Kratz, Department of Paediatric Haematology and Oncology, Hanover Medical School,

since 2012. "The purchased goods are concealed, hidden, excused, not unpacked or hoarded," explains Professor Müller. "The buying habits are concealed or played down for a long time, but over time lead to [...] secretary Christina Bartels, telephone (0511)-532-3136. For further information , please contact Professor Astrid Müller, Department of Psychosomatics and Psychotherapy, telephone (0511)-532-6569. Registration

positioned for the major tasks ahead, as President Professor Dr. Michael Manns explains: "With Martina Saurin, responsible for finances and administration, Professor Frank Lammert, responsible for patient care

counselling and diagnostics to those affected by a tumour risk syndrome across the board," says Professor Dr Brigitte Schlegelberger, head of the Institute of Human Genetics at the MHH. The Innovation Fund [...] keep pace with this development and ensure comprehensive human genetics care in the future," says Professor Schlegelberger. The project will start in July 2021 and will be supported over four years with a

they do occur more frequently and are sometimes more severe than previously thought," explains Professor Dr Thomas Skripuletz. Testing for Sjögren's is routine at the MHH's Department of Neurology, pa [...] drugs could also help with Sjögren's and which are more likely to have a negative effect," explains Professor Skripuletz. Promising therapeutic approaches could also be the starting point for a clinical trial

February 2022 and continued to plan the constructional development at Stadtfelddamm. MHH President Professor Dr. Michael Manns is pleased that with Sascha Zenker, an accomplished expert and developer of Lower [...] are gaining a committed and hands-on manager who can get to grips with the matter immediately." Professor Manns thanks Vice President Saurin for the additional work she has done. Martina Saurin will continue

(ESMO). The guidelines have now been published in the journal Annals of Oncology. Gastroenterologist Professor Dr. Arndt Vogel of Hannover Medical School (MHH) and member of the ESMO Steering Committee played [...] although unfortunately many patients are not operable when they are first diagnosed," explains Professor Vogel, who is a senior consultant in the Department of Gastroenterology, Hepatology and Endocrinology